Information Brief on Menopause and Myalgic Encephalomyelitis (ME/CFS)

Purpose: This brief explores the relationship between menopause and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), emphasizing that menopause is a separate medical condition and requires distinct diagnostic and treatment considerations.

Key Points:

1. Menopause and ME/CFS Are Separate Conditions
   • Menopause and ME/CFS are independent conditions, and treatments for menopause do not address or cure ME/CFS.
2. Menopause Diagnosis
   • Menopause typically occurs between the ages of 45–55 but can begin earlier (e.g., after a hysterectomy) and may last five years.
   • It results from ovarian failure and must be confirmed through testing:
     • Plasma Follicle Stimulating Hormone (FSH) levels
     • Oestradiol levels
   • Symptoms alone cannot reliably diagnose menopause, as they vary and may be insignificant.
3. Expert Guidance for Menopause Treatment
   • Dr. Dowsett recommends consulting experts at Women’s Clinics or Family Planning Clinics for guidance on treatment options, which include:
     • Patches, depot injections, ovarian hormones, and various drugs.
     • Some medications carry risks, such as cardiovascular problems, and others cannot be prescribed if the patient still has a uterus.
4. Recommended Resources
   • Dr. Dowsett advises exploring the book Key Topics in Obstetrics and Gynaecology by SLADE RJ, LAIRDE, BEYNON G, and PICKERS GILL A (Bios Scientific Publishers, Oxford and Washington DC), estimated to cost around £14–15.

Target Audience:

• Healthcare Professionals: Clinicians managing patients with both menopause and ME/CFS.
• Advocates and Patients: Individuals seeking clear distinctions between menopause and ME/CFS and informed treatment recommendations.
• Family Planning and Women’s Health Clinics: Entities offering expertise on menopause treatments.

Overall Outcome: This brief underscores the importance of accurate diagnosis and specialized treatment for menopause, with advice tailored to individual patient needs. It clarifies that menopause management is unrelated to ME/CFS treatment, emphasizing distinct medical approaches for each condition.